Prarthna Bhardwaj to Breast Neoplasms
This is a "connection" page, showing publications Prarthna Bhardwaj has written about Breast Neoplasms.
Connection Strength
3.837
-
Bhardwaj PV, Abdou Y. Managing pregnancy-associated breast cancer: A practical approach. Semin Perinatol. 2025 Mar; 49(2):152037.
Score: 0.520
-
Avelino ARM, Pulipati S, Jamouss K, Bhardwaj PV. Updates in Treatment of HER2-positive Metastatic Breast Cancer. Curr Treat Options Oncol. 2024 Dec; 25(12):1471-1481.
Score: 0.508
-
Bhardwaj PV, Abdou Y. Navigating Treatment Pathways in Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies. J Clin Oncol. 2024 Dec; 42(34):4012-4017.
Score: 0.503
-
Bhardwaj PV, Gupta S, Elyash A, Teplinsky E. Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship. Curr Oncol Rep. 2024 01; 26(1):34-45.
Score: 0.479
-
Bhardwaj PV, Abdou YG. The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer. Oncologist. 2023 10 03; 28(10):832-844.
Score: 0.470
-
Bhardwaj PV, Dulala R, Rajappa S, Loke C. Breast Cancer in India: Screening, Detection, and Management. Hematol Oncol Clin North Am. 2024 02; 38(1):123-135.
Score: 0.461
-
Bhardwaj PV, Mason H, Kaufman SA, Visintainer P, Makari-Judson G. Outcomes of a Multidisciplinary Team in the Management of Patients with Early-Stage Breast Cancer Undergoing Neoadjuvant Chemotherapy at a Community Cancer Center. Curr Oncol. 2023 05 08; 30(5):4861-4870.
Score: 0.457
-
Bhardwaj PV, Abdou YG. Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications. Curr Oncol Rep. 2022 12; 24(12):1791-1800.
Score: 0.440